fruzaqla

Generic: fruquintinib

Labeler: takeda pharmaceuticals america, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name fruzaqla
Generic Name fruquintinib
Labeler takeda pharmaceuticals america, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

fruquintinib 5 mg/1

Manufacturer
Takeda Pharmaceuticals America, Inc.

Identifiers & Regulatory

Product NDC 63020-225
Product ID 63020-225_692e8d28-13e4-43ae-8ea9-f2de3bc73d06
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA217564
Listing Expiration 2027-12-31
Marketing Start 2023-11-08

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63020225
Hyphenated Format 63020-225

Supplemental Identifiers

RxCUI
2670184 2670190 2670196 2670198
UNII
49DXG3M5ZW

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fruzaqla (source: ndc)
Generic Name fruquintinib (source: ndc)
Application Number NDA217564 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE
source: ndc

Packages (1)

63020-225-21 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE

Ingredients (1)

fruquintinib (5 mg/1)

Linked Drug Pages (1)

Fruzaqla ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "692e8d28-13e4-43ae-8ea9-f2de3bc73d06", "openfda": {"unii": ["49DXG3M5ZW"], "rxcui": ["2670184", "2670190", "2670196", "2670198"], "spl_set_id": ["186d786e-dc8a-45f2-b5e1-01ac0201879f"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63020-225-21)  / 21 CAPSULE in 1 BOTTLE", "package_ndc": "63020-225-21", "marketing_start_date": "20231108"}], "brand_name": "Fruzaqla", "product_id": "63020-225_692e8d28-13e4-43ae-8ea9-f2de3bc73d06", "dosage_form": "CAPSULE", "product_ndc": "63020-225", "generic_name": "fruquintinib", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fruzaqla", "active_ingredients": [{"name": "FRUQUINTINIB", "strength": "5 mg/1"}], "application_number": "NDA217564", "marketing_category": "NDA", "marketing_start_date": "20231108", "listing_expiration_date": "20271231"}